Equities analysts expect NutriSystem Inc. (NASDAQ:NTRI) to announce $131.20 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for NutriSystem’s earnings. The lowest sales estimate is $129.90 million and the highest is $132.00 million. NutriSystem posted sales of $131.24 million in the same quarter last year, which would indicate a negative year over year growth rate of 0%. The firm is scheduled to issue its next quarterly earnings results on Monday, February 25th.
On average, analysts expect that NutriSystem will report full-year sales of $692.70 million for the current financial year, with estimates ranging from $691.40 million to $693.50 million. For the next financial year, analysts expect that the firm will report sales of $749.40 million, with estimates ranging from $744.00 million to $755.10 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that that provide coverage for NutriSystem.
NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.54. The business had revenue of $159.30 million for the quarter, compared to analysts’ expectations of $164.18 million. NutriSystem had a net margin of 8.06% and a return on equity of 43.46%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share.
A number of brokerages recently issued reports on NTRI. ValuEngine raised shares of NutriSystem from a “strong sell” rating to a “sell” rating in a research note on Friday, August 3rd. Zacks Investment Research cut shares of NutriSystem from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Barrington Research reissued a “hold” rating on shares of NutriSystem in a research note on Wednesday, August 1st. BidaskClub cut shares of NutriSystem from a “hold” rating to a “sell” rating in a research note on Saturday, August 18th. Finally, DA Davidson cut shares of NutriSystem from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $45.00 to $40.00 in a research note on Tuesday, July 31st. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company’s stock. NutriSystem currently has an average rating of “Hold” and an average target price of $45.57.
NASDAQ:NTRI traded down $0.37 during mid-day trading on Wednesday, reaching $37.07. The stock had a trading volume of 404,463 shares, compared to its average volume of 1,060,736. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 1.39 and a beta of 1.04. NutriSystem has a 12 month low of $26.06 and a 12 month high of $55.10.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 19th. Shareholders of record on Friday, November 9th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.70%. NutriSystem’s payout ratio is presently 51.02%.
NutriSystem announced that its board has authorized a share repurchase program on Tuesday, October 30th that authorizes the company to buyback $75.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 7.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.
Several hedge funds and other institutional investors have recently bought and sold shares of NTRI. Trexquant Investment LP lifted its holdings in NutriSystem by 475.9% in the third quarter. Trexquant Investment LP now owns 55,658 shares of the company’s stock valued at $2,062,000 after buying an additional 45,993 shares during the period. Elk Creek Partners LLC lifted its holdings in NutriSystem by 1.8% in the third quarter. Elk Creek Partners LLC now owns 442,412 shares of the company’s stock valued at $16,391,000 after buying an additional 7,658 shares during the period. Rafferty Asset Management LLC acquired a new position in NutriSystem in the third quarter valued at $313,000. BBT Capital Management LLC acquired a new position in NutriSystem in the third quarter valued at $877,000. Finally, BlackRock Inc. lifted its holdings in NutriSystem by 1.6% in the third quarter. BlackRock Inc. now owns 4,418,221 shares of the company’s stock valued at $163,695,000 after buying an additional 71,717 shares during the period.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.